Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
about
Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesityEffects of selective and non-selective glucocorticoid receptor II antagonists on rapid-onset diabetes in young rats11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models.A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding.Involvement of GR and p300 in the induction of H6PD by cortisol in human amnion fibroblasts.Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposityTransgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice.Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.Effect of Mifepristone on Corticosteroid Production in Vitro by Adrenal Glands of Rats with Streptozotocin Diabetes.Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity.
P2860
Q27302419-691A3454-684A-4E91-B48D-345B3F9FE884Q28541028-CD5B51C4-2C62-47F6-A1E9-001E6B8030E3Q34800976-772284AC-56DA-4F9C-A424-B40F77CE3485Q35106896-90E019F8-3526-4A8B-8AA6-C4E09E370E5FQ36179979-32138573-E899-4674-9691-D2B0E824AC6EQ36439638-C0CF7E12-946A-46F3-8CB4-34EEBA7ED7DCQ37146798-A6C1DA6E-BF55-4770-B390-6728AAF76FEFQ37629023-34A4A46E-D885-498B-AE43-BA63E3D0E543Q39220866-C7A11E59-F55D-476F-AF16-C4440338E1DBQ42540788-BA37AA51-BDFE-4531-AB5B-E47E62245FD7Q42602503-DF523E09-231D-4244-8741-4403C04884C4Q48019755-AC717A14-3183-48EA-8854-3AD2D042F5F9Q51188763-AD5F33A8-A048-4BFD-81A8-C9DFB4F99CE3Q52641727-8FD39B91-4D22-432D-BBDB-A3682E6B8BCE
P2860
Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@en
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@nl
type
label
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@en
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@nl
prefLabel
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@en
Tissue-specific dysregulation ...... as a model of type 2 diabetes.
@nl
P2093
P2860
P1433
P1476
Tissue-specific dysregulation ...... as a model of type 2 diabetes
@en
P2093
T C Friedman
Y Nakagawa
P2860
P2888
P304
P356
10.1007/S00125-010-1956-9
P577
2010-11-04T00:00:00Z